Robustness of outcomes in trials evaluating sodium–glucose co‐transporter 2 inhibitors for heart failure

AIMS: Recent trials have evaluated sodium–glucose co‐transporter 2 inhibitors in patients with heart failure (HF). We sought to assess the robustness of findings from these trials using the fragility index (FI). METHODS AND RESULTS: Fragility index is defined as the minimum number of patients that m...

Descripción completa

Detalles Bibliográficos
Autores principales: Usman, Muhammad Shariq, Khan, Muhammad Shahzeb, Fonarow, Gregg C., Greene, Stephen J., Friede, Tim, Vaduganathan, Muthiah, Filippatos, Gerasimos, Coats, Andrew J. Stewart, Anker, Stefan D., Butler, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934993/
https://www.ncbi.nlm.nih.gov/pubmed/35029056
http://dx.doi.org/10.1002/ehf2.13785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934993/
https://www.ncbi.nlm.nih.gov/pubmed/35029056
http://dx.doi.org/10.1002/ehf2.13785

Ejemplares similares